Scientists at the University of Cambridge have successfully used artificial intelligence to design a new type of vaccine containing a component known as a “super-antigen” that could provide broad protection against coronaviruses and potentially prevent pandemics, according to research published in the Journal of Infection.
The approach represents a departure from traditional vaccine development methods. Rather than designing vaccines based on current virus strains, the team analyzed genetic sequences from multiple coronaviruses obtained through global surveillance programs. Artificial intelligence then processed this data to create an antigen capable of training the immune system to recognize and fight an entire family of viruses, even those that mutate or jump from animal populations to humans.
Initial human trials involving 39 participants assessed the vaccine’s safety profile. Results showed the immune system impact was “modest,” though researchers report continued enthusiasm for the approach. A second trial involving approximately 200 people is planned to better understand how effectively the vaccine trains immune responses. Professor Jonathan Heeney from Cambridge emphasized that the work represents a fundamental shift in pandemic preparedness, moving from reactive responses to current threats toward proactive protection against future outbreaks.
The Cambridge team is expanding the technology’s application to additional vaccine candidates. Researchers are conducting animal studies on universal seasonal flu vaccines designed to eliminate the need for annual reformulation and are investigating vaccines for H5N1 bird flu and viral hemorrhagic fevers including Ebola species. Outside experts acknowledge the potential of AI-designed vaccines while noting that human immune systems, shaped by years of infection exposure, may respond differently than laboratory models.
Government officials and independent scientists have characterized the work as a significant scientific achievement with potential to accelerate vaccine development timelines and improve global health outcomes.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI